Search Tag: Ultibro

Pharmacy Management

2014 10 Sep

Novartis has recently presented data which show that Ultibro, its drug for chronic obstructive pulmonary disease (COPD), is superior in reducing flare-ups as compared to GlaxoSmithKline's blockbuster Seretide. The data is from the Phase III head-to-head LANTERN study that was presented at the European Respiratory Society Congress in Munich....Read more